/주식/ILMN
ILMN

ILMN

USD

Illumina Inc. Common Stock

$121.900+1.690 (1.406%)

실시간 가격

Healthcare
Diagnostics & Research
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$120.210

고가

$122.075

저가

$119.360

거래량

1.86M

기업 기본 정보

시가총액

18.6B

산업

Diagnostics & Research

국가

United States

거래 통계

평균 거래량

1.68M

거래소

NMS

통화

USD

52주 범위

저가 $68.7현재가 $121.900고가 $153.06

AI 분석 리포트

마지막 업데이트: 2025년 11월 3일
AI 생성데이터 소스: Yahoo Finance, Bloomberg, SEC

Illumina (ILMN): Decoding Market Signals Amid Analyst Upgrades and AI Predictions

Price Action Reality Check

After a rocky Q3 that saw the stock bottom out at $91.30 (Sep 25), Illumina exploded higher in late October. The October 31 print of $123.54 marked a 24.7% single-day surge--the largest move since early August. This came on 6.5x average volume, suggesting institutional buying power behind the rally. While the stock now sits 44% above its 52-week low and 24% below its 52-week high, the aggressive jump leaves technical questions about sustainability.

News Sentiment Breakdown

Analysts split on Illumina’s prospects:

  • Evercore ISI (Outperform, $142 target) and UBS (Neutral, $120) highlight bullish extremes
  • Barclays ($100 target) remains cautious amid upgrades
  • Mixed messaging: 21.9% average upside across analyst targets vs. current $123.54 price

The October 30 earnings release appears to be the catalyst for this divergence. Technicals show conflicting signals:

  • Bullish: RSI at

관련 뉴스

Analyst Upgrades

Barclays Maintains Underweight on Illumina, Raises Price Target to $100

Barclays analyst Luke Sergott maintains Illumina with a Underweight and raises the price target from $95 to $100.

더 보기
Barclays Maintains Underweight on Illumina, Raises Price Target to $100
Analyst Upgrades

Canaccord Genuity Maintains Hold on Illumina, Raises Price Target to $112

Canaccord Genuity analyst Kyle Mikson maintains Illumina with a Hold and raises the price target from $105 to $112.

더 보기
Canaccord Genuity Maintains Hold on Illumina, Raises Price Target to $112
Analyst Upgrades

JP Morgan Maintains Neutral on Illumina, Raises Price Target to $105

JP Morgan analyst Casey Woodring maintains Illumina with a Neutral and raises the price target from $100 to $105.

더 보기
JP Morgan Maintains Neutral on Illumina, Raises Price Target to $105
Analyst Upgrades

TD Cowen Maintains Hold on Illumina, Raises Price Target to $115

TD Cowen analyst Dan Brennan maintains Illumina with a Hold and raises the price target from $110 to $115.

더 보기
TD Cowen Maintains Hold on Illumina, Raises Price Target to $115
Analyst Upgrades

UBS Maintains Neutral on Illumina, Raises Price Target to $120

UBS analyst John Sourbeer maintains Illumina with a Neutral and raises the price target from $110 to $120.

더 보기
UBS Maintains Neutral on Illumina, Raises Price Target to $120
Analyst Upgrades

Evercore ISI Group Maintains Outperform on Illumina, Raises Price Target to $142

Evercore ISI Group analyst Vijay Kumar maintains Illumina with a Outperform and raises the price target from $132 to $142.

PR Newswire

Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025

Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the third quarter of fiscal year 2025. "I am...

AI 예측Beta

AI 추천

강세

업데이트 시간: 2025년 11월 10일 오전 11:53

약세중립강세

67.3% 신뢰도

리스크 & 트레이딩

리스크 수준3/5
중위험
적합 대상
보수적
트레이딩 가이드

진입점

$121.46

익절

$129.89

손절

$109.68

핵심 요소

PDI 9.3 is above MDI 5.0 with ADX 15.0, suggesting bullish trend
현재 가격이 지지선($121.27)에 매우 근접하여 강력한 매수 기회를 시사합니다.
거래량은 평균(17,664)의 4.5배로 극도로 강력한 매수 압력을 나타냅니다.
MACD 0.1239이(가) 신호선 0.1247 아래에 있어 약세 교차를 나타냅니다.

최신 정보 받기

가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기